Immunogenicity of Hepatitis B Vaccination Among Drug Users

PHASE4CompletedINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

October 31, 2015

Conditions
Hepatitis B Vaccination
Interventions
BIOLOGICAL

60 µg dose hepatitis B vaccine

three-dose, 60 µg per dose

BIOLOGICAL

20 µg dose hepatitis B vaccine

three-dose, 20 µg per dose

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention, China

OTHER_GOV

lead

Shanxi Medical University

OTHER

NCT02959775 - Immunogenicity of Hepatitis B Vaccination Among Drug Users | Biotech Hunter | Biotech Hunter